Clinical Trials Directory

Trials / Recruiting

RecruitingNCT07504003

Influence of Training Session Duration on Improvements in Physiological Resilience to Exercise

Status
Recruiting
Phase
N/A
Study type
Interventional
Enrollment
40 (estimated)
Sponsor
Centre Hospitalier Universitaire de Saint Etienne · Academic / Other
Sex
All
Age
18 Years – 45 Years
Healthy volunteers
Accepted

Summary

During prolonged endurance exercise, certain physiological variables deteriorate depending on the duration of the exercise. Physiological resilience has therefore been defined as the ability to resist these changes and appears to be an important performance factor in endurance sports. For example, most studies in this field have investigated changes in cycling power output associated with the first ventilatory threshold (VT1), a marker of an individual's endurance capacity, after prolonged endurance exercise. To date, only two studies have examined the effects of training on resilience. The first compared the effectiveness of two training programs, one with low-intensity sessions and the other with high-intensity sessions, with no difference between the conditions. The second study showed that incorporating strength training into a running training program was more effective at improving resilience than running alone. However, the influence of training session duration on resilience remains unknown. Only one observational study has shown that in a group of runners of similar ability, those who were used to doing long sessions had better resilience than those who only did short sessions.

Detailed description

We hypothesize that at equal intensity and volume, a less frequent training consisting of long sessions would be more effective in improving physiological resilience than a more frequent training composed of short sessions.

Conditions

Interventions

TypeNameDescription
OTHERLong sessionsTraining frequency of 2 long sessions per week
OTHERShort sessionsTraining frequency of 5 short sessions per week

Timeline

Start date
2026-04-08
Primary completion
2028-11-15
Completion
2029-02-28
First posted
2026-03-31
Last updated
2026-04-14

Locations

1 site across 1 country: France

Source: ClinicalTrials.gov record NCT07504003. Inclusion in this directory is not an endorsement.